Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeoVax

M&A STATUS
Reverse Merger LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of vaccines. The company is engaged in developing vaccines for several infectious diseases including H5N1 influenza virus.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 6812 Idylwild
  • Boulder, CO 80301
  • United States

NeoVax Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NeoVax‘s full profile, request access.

Request full access to PitchBook

NeoVax Executive Team (1)

Name Title Board
Seat
Contact
Info
Jose Sandoval President